Navigation Links
ProMetic reports continued positive data in PBI-1402 phase II trial in chemotherapy-induced anemia
Date:3/6/2008

- Update on Clinical Developments

MONTREAL, March 6 /PRNewswire-FirstCall/ - ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic") announces favorable top-line findings from the third cohort in its Phase II trial with PBI-1402 in patients with chemotherapy-induced anemia ("CIA"). Analysis of the compiled data from a total of 18 patients showed an overall statistically significant increase of the mean hematocrit values at weeks 4, 6 and 8, and of the hemoglobin values at week 8. At week 8, p values were 0.02 for hematocrit and hemoglobin. More detailed results from the study have been submitted to the European Hematology Association for presentation at their June 2008 meeting in Copenhagen.

"These results are very encouraging and continue to demonstrate the efficacy and safety profile of PBI-1402, a non-EPO (erythropoietin) treatment for CIA," states Mr. Pierre Laurin, President and Chief Executive Officer of ProMetic Life Sciences Inc. "We are excited about the prospects for PBI-1402 for the treatment of anemia in oncology since, unlike EPO, PBI-1402 demonstrated some anticancer activity in animal models. We look forward to sharing more detailed clinical trial results."

Other PBI-1402 development highlights include the extension of the enrollment for the PBI-1402 CIA trial to include an additional 12 patients receiving the lowest trial dose. Data from these additional patients are expected by June 2008.

In addition, a new Phase II study in patients with anemia resulting from chronic kidney disease has been scheduled. This multi-center study will be placebo controlled and will examine the effect of PBI-1402 on anemia, as well as several other clinical parameters. Conclusive results obtained recently in animal models have confirmed the erythropoiesis activity of PBI-1402 even when there is little or no endogenous EPO produced by the kidney.

About PBI-1402

PBI-1402 is an orally active compound being develo
'/>"/>

SOURCE PROMETIC LIFE SCIENCES INC.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. ProMetic announces signature of definitive license agreement with Kedrion for two hyperimmune products
2. ProMetic provides business update - Over $35 million worth of business secured in January
3. ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use
4. ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies
5. VaxGen Reports Financial Update
6. EntreMed Reports Fourth Quarter and Year-End 2007 Financial Results
7. Major Medical Journal Reports Higher Success, Fewer Complications and Lower Cost Treating DVT With Trellis(R) Isolated Thrombolysis Compared With Catheter-Directed Thrombolysis
8. Acura Pharmaceuticals, Inc. Reports 2007 4th Quarter and Annual Financial Results; Sets 2008 Expectations
9. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
10. BioCryst Reports Fourth Quarter and Year End 2007 Financial Results and Corporate Update
11. MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., HOUSTON, Nov. 24 IES (...ectrical and communications systems and services f...ets, announced today that its commercial business ...orcon JV to install the electrical systems for the...ty at the U.S. Army Medical Research Institute of ...
(Date:11/24/2009)...LGARY and BLENHEIM, Ontario, Nov. 24 /PRNewswire-F...ay it is acquiring the assets of Hyland Seeds, a d... The addition of Hyland Seeds will further expand ...mpany anticipates the introduction of SmartStax(T...erant Trait Technology in corn in 2012. The transa...
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24 /PR...aq: DCGN ) today announced the approval of all of ...rt for the District of Delaware,(the "Bankruptcy C...n for,relief under Chapter 11 of the United States... The orders issued by the Bankruptcy Court all...
(Date:11/24/2009)...ATTLE, Nov. 24 Blue Marble Energy ...ssa Public Development Authority (OPDA) were recen...nity Economic Revitalization Board (CERB) in a pri...irst specialty biochemical biorefinery in Lincoln ...antly speed the development of our biorefinery and...
Breaking Biology Technology:Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2
... With an increased demand for a...ed the release of the new Super-File and Mini-File...l-in-one, turnkey, and affordable to consumers nat... (PRWEB) May 20, 2009 -- With an increased demand ...nounced the release of the new Super-File and Mini...
...Access Given to Support the Global R&D and Hea...y 20 In support of the efforts of the global heal...tbreaks such as the current Influenza A (H1N1) flu...Thomson Reuters, the world,s leading source of int...als, today announced the free availability of its ...
...ORK, May 20 Keryx Biopharmaceuticals, Inc. (the "...pointment of Ron Bentsur as Chief Executive Office...Bentsur will join the Company,s Board of Directors...09. , , Michael P. Tarnok, Interim Chairman of th... of the Board, I want to welcome Ron Bentsur to Ke...
Other Biology Technology:Dealzer Hydroponics Introduces the Super-File Cabinet Grow Box System 2Thomson Reuters Makes Disease Briefing on Influenza Covering H1N1 (Swine Flu) Publicly Available 2Thomson Reuters Makes Disease Briefing on Influenza Covering H1N1 (Swine Flu) Publicly Available 3Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer 2Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer 3Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer 4
(Date:11/25/2009)... JOLLA, CAWhen you eat may be just as vital to you... Salk Institute for Biological Studies. Their expe... waning of thousands of genes in the liverthe body...food intake and not by the body,s circadian clock ...me determines the activity of a large number of ge...
(Date:11/24/2009)...et science is opening new doors to understanding h...the hearing of a marine mammal or if they hear it...ed X-ray scanners that NASA uses to detect flaws i...is now allowing scientists to peek inside the gian...d three-dimensional replicas of a whale,s hearing ...
(Date:11/24/2009)...atomic-level action of a remarkable class of ring-...chers with the Lawrence Berkeley National Laborato... crystallography beamline at the Advanced Light So...s in gene expression and replication, and are vita... as infectious agents, such as the human papilloma...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3Rocket science leads to new whale discovery 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Beacon Equity Researches 3A Sanofi Aventis Amazon Yahoo Johnson 26 Johnson Novavax and NexMed 50508 1Beacon Equity Researches 3A Sanofi Aventis Amazon Yahoo Johnson 26 Johnson Novavax and NexMed 50508 2Beacon Equity Researches 3A Sanofi Aventis Amazon Yahoo Johnson 26 Johnson Novavax and NexMed 50508 3Industry Leader Announces Next Generation of Patient Flow Automation 50505 1Industry Leader Announces Next Generation of Patient Flow Automation 50505 2Industry Leader Announces Next Generation of Patient Flow Automation 50505 3Emerging Techniques Put a New Twist on Ankle Repair 50502 1Emerging Techniques Put a New Twist on Ankle Repair 50502 2Emerging Techniques Put a New Twist on Ankle Repair 50502 3
...ns of instruments to be deployed on the Oak Ridge ... provide valuable information related to climate c...us diseases and other areas of interest. , Walker...ment of Energy reservation will be part of the Nat...de continental-scale research platform supported b...
...he highlands of Mexico about 10,000 years ago and ...e world. It is a member of the grass family, whi...ing rice, wheat, barley, sorghum, and sugar cane. ...esirable traits, they were also selecting genes im...plant. Since that time, Mexican farmers have crea...
...m Latvia cast light on a key event in our own evol...r and ventured onto land. Swedish researchers Per ...ave reconstructed parts of the animal and explain ... It has long been known that the first backboned ...hibians, reptiles, birds and mammals, including ou...
Other Biology News:Oak Ridge pegged for national ecological network 2Ancient Mexican maize varieties 2Ancient Mexican maize varieties 3Closing the gap between fish and land animals 2
GIBCO Keratinocyte-SFM (1X) liquid from Invitrogen
GIBCO Dulbecco's Phosphate-Buffered Saline (D-PBS) (1X) liquid from Invitrogen
GIBCO Penicillin-Streptomycin liquid from Invitrogen
GIBCO Streptomycin Sulfate from Invitrogen
Biology Products: